Unstable angina / non ST elevation myocardial infarction anticoagulant therapy


 * Associate Editors-in-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.; Smita Kohli, M.D.

Overview
Anticoagulation, traditionally with unfractionated heparin (UFH), is a cornerstone of therapy for patients with Unstable angina/NSTEMI. Some of the agents available in this category include: These agents are also sometimes referred to as antithrombins, although, it should be noted that they often inhibit one or more proteins in the coagulation cascade before thrombin.
 * unfractionated heparin,
 * low molecular weight heparin,
 * Direct Thrombin Inhibitors (e.g.,bivalirudin)
 * Factor Xa Inhibitors (e.g.,fondaparinux), and
 * warfarin.

Anticoagulant therapy in UA/NSTEMI

 * You can read in greater detail about each of the therapies below in greater detail by clicking on the link for that therapy.

Unfractionated Heparin | Low Molecular Weight Heparin | Direct Thrombin Inhibitors | Factor Xa Inhibitors | Long Term Anticoagulation


 * You can also read the ACC/AHA Guidelines for anticoagulation here